JP2018509934A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018509934A5 JP2018509934A5 JP2017562131A JP2017562131A JP2018509934A5 JP 2018509934 A5 JP2018509934 A5 JP 2018509934A5 JP 2017562131 A JP2017562131 A JP 2017562131A JP 2017562131 A JP2017562131 A JP 2017562131A JP 2018509934 A5 JP2018509934 A5 JP 2018509934A5
- Authority
- JP
- Japan
- Prior art keywords
- mir
- methylation
- marker
- expression level
- mirna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15156389.7 | 2015-02-24 | ||
| EP15156389 | 2015-02-24 | ||
| PCT/EP2016/053813 WO2016135168A1 (en) | 2015-02-24 | 2016-02-24 | Biomarker panel for the detection of cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020202783A Division JP2021052777A (ja) | 2015-02-24 | 2020-12-07 | 癌の検出のためのバイオマーカーパネル |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018509934A JP2018509934A (ja) | 2018-04-12 |
| JP2018509934A5 true JP2018509934A5 (cg-RX-API-DMAC7.html) | 2019-03-14 |
| JP6807873B2 JP6807873B2 (ja) | 2021-01-13 |
Family
ID=52589264
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017562131A Expired - Fee Related JP6807873B2 (ja) | 2015-02-24 | 2016-02-24 | 癌の検出のためのバイオマーカーパネル |
| JP2020202783A Pending JP2021052777A (ja) | 2015-02-24 | 2020-12-07 | 癌の検出のためのバイオマーカーパネル |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020202783A Pending JP2021052777A (ja) | 2015-02-24 | 2020-12-07 | 癌の検出のためのバイオマーカーパネル |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10941451B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3262190B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6807873B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20170120124A (cg-RX-API-DMAC7.html) |
| CN (1) | CN107406880A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2016223532B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2975952C (cg-RX-API-DMAC7.html) |
| DK (1) | DK3262190T3 (cg-RX-API-DMAC7.html) |
| EA (1) | EA037995B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2893297T3 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1246828A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL253756B (cg-RX-API-DMAC7.html) |
| MX (1) | MX386750B (cg-RX-API-DMAC7.html) |
| PL (1) | PL3262190T3 (cg-RX-API-DMAC7.html) |
| UA (1) | UA124612C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016135168A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018236065A1 (ko) * | 2017-06-21 | 2018-12-27 | 사회복지법인 삼성생명공익재단 | 대장암 환자의 항암제 치료 반응성 예측용 마커 |
| KR102100557B1 (ko) * | 2017-06-21 | 2020-04-14 | 사회복지법인 삼성생명공익재단 | 대장암 환자의 항암제 치료 반응성 예측용 마커 |
| JP6614630B2 (ja) * | 2017-08-23 | 2019-12-04 | 国立研究開発法人国立がん研究センター | 肝細胞癌のリスク評価方法 |
| WO2019081507A1 (en) | 2017-10-23 | 2019-05-02 | Universität Heidelberg | NEW MARKERS DERIVED FROM BLOOD FOR CANCER DETECTION |
| JP7326764B2 (ja) * | 2018-03-09 | 2023-08-16 | 東ソー株式会社 | 腫瘍マーカーならびに腫瘍細胞を夾雑細胞と区別して回収および検出する方法 |
| CA3127154A1 (en) * | 2019-02-21 | 2020-08-27 | Universitat Heidelberg | Biomarker panel for diagnosis and prognosis of cancer |
| GB201906199D0 (en) * | 2019-05-02 | 2019-06-19 | Belgian Volition Sprl | Method for the detection of cancer |
| CN110136776B (zh) * | 2019-05-15 | 2021-04-20 | 深圳大学 | 一种从低质量核糖体印迹数据预测基因编码框的方法和系统 |
| CN110269869B (zh) * | 2019-07-30 | 2023-03-31 | 宁夏医科大学 | 一种以蜥蜴为主的抗肿瘤药物及验证方法 |
| CN112176419B (zh) * | 2019-10-16 | 2022-03-22 | 中国医学科学院肿瘤医院 | 一种检测ctDNA中肿瘤特异基因的变异和甲基化的方法 |
| CN113186279B (zh) * | 2020-01-14 | 2024-07-02 | 腾辰生物科技(上海)有限公司 | 用于辅助诊断癌症的透明质酸酶甲基化标志物及试剂盒 |
| CN118460718A (zh) * | 2020-01-15 | 2024-08-09 | 腾辰生物科技(上海)有限公司 | 一种用于辅助诊断食管癌的钙结合蛋白甲基化标志物 |
| CN118360405A (zh) * | 2020-01-19 | 2024-07-19 | 腾辰生物科技(上海)有限公司 | 一种甲基化标志物在辅助诊断食管癌中的应用 |
| CN118460720A (zh) * | 2020-02-04 | 2024-08-09 | 腾辰生物科技(上海)有限公司 | 一种辅助诊断食管癌的甲基化标志物 |
| CN113215250B (zh) * | 2020-02-04 | 2024-04-30 | 腾辰生物科技(上海)有限公司 | 一个基因的甲基化水平在辅助诊断癌症中的应用 |
| CN113528635B (zh) * | 2020-04-16 | 2024-06-11 | 腾辰生物科技(上海)有限公司 | 一种印记基因的甲基化作为心脑血管疾病早期诊断的标志物 |
| US20230340607A1 (en) * | 2020-07-13 | 2023-10-26 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Compositions and methods for detecting gene fusions of rad51ap1 and dyrk4 and for diagnosing and treating cancer |
| CN114480630B (zh) * | 2020-10-26 | 2024-09-06 | 腾辰生物科技(上海)有限公司 | 用于辅助诊断癌症的一种甲基化标志物 |
| US20240093306A1 (en) * | 2021-02-04 | 2024-03-21 | The Cleveland Clinic Foundation | Micro rna liver cancer markers and uses thereof |
| CN115341027B (zh) * | 2021-05-13 | 2025-08-26 | 高飞 | 急性淋巴细胞白血病dna甲基化标志物及其应用 |
| JP7143480B1 (ja) * | 2021-06-10 | 2022-09-28 | 株式会社大一商会 | 遊技機 |
| CN114875131A (zh) * | 2022-04-24 | 2022-08-09 | 上海市东方医院（同济大学附属东方医院） | 靶向膜蛋白甲基化作为印记基因综合征标志物的检测方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030211606A1 (en) * | 2002-05-10 | 2003-11-13 | Isis Pharmaceuticals Inc. | Antisense modulation of DYRK4 expression |
| WO2005007892A1 (en) * | 2003-07-03 | 2005-01-27 | Gentron, Llc | Methods and systems for diagnosis of non-cenral nervous system (cns) diseases in cns samples |
| KR20070004725A (ko) * | 2004-02-20 | 2007-01-09 | 더 리전츠 오브 더 유니버시티 오브 캘리포니아 | 타액 ｍＲＮＡ 프로파일링, 생물 마커 및 관련 방법 및부품 키트 |
| CN104846092A (zh) * | 2007-02-21 | 2015-08-19 | 奥斯陆大学医院Hf | 新型癌症标记物 |
| WO2009067655A2 (en) * | 2007-11-21 | 2009-05-28 | University Of Florida Research Foundation, Inc. | Methods of feature selection through local learning; breast and prostate cancer prognostic markers |
| CN101245386A (zh) * | 2008-03-26 | 2008-08-20 | 中南大学 | 用于多种肿瘤抑瘤基因检测的cDNA芯片 |
| US7897356B2 (en) | 2008-11-12 | 2011-03-01 | Caris Life Sciences | Methods and systems of using exosomes for determining phenotypes |
| JP2011097833A (ja) * | 2009-11-04 | 2011-05-19 | Takeshi Zama | 特定の遺伝子のメチル化の頻度を、頭頸部腫瘍のバイオマーカーとして使用する方法 |
| JPWO2011105570A1 (ja) | 2010-02-26 | 2013-06-20 | シスメックス株式会社 | 生体試料中の癌細胞の存否を判定する方法、判定用分子マーカーおよびキット |
| WO2012174282A2 (en) | 2011-06-16 | 2012-12-20 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Biomarker compositions and methods |
| JP2013027387A (ja) * | 2011-06-21 | 2013-02-07 | Tohoku Univ | 膵臓癌バイオマーカー |
| WO2012175562A2 (en) * | 2011-06-21 | 2012-12-27 | University Of Tartu | Methylation and microrna markers of early-stage non-small cell lung cancer |
| US10316367B2 (en) * | 2012-06-21 | 2019-06-11 | Ruprecht-Karls-Universität Heidelberg | Circulating miRNAs as markers for breast cancer |
| EP2682477A1 (en) * | 2012-07-06 | 2014-01-08 | National University of Ireland, Galway | miR-181a and miR652 as oncologic biomarker of breast cancer |
| WO2014020048A1 (en) * | 2012-07-31 | 2014-02-06 | Ruprecht-Karls-Universität Heidelberg | Hyal2 methylation and expression as a cancer marker |
| JP2014036637A (ja) * | 2012-08-20 | 2014-02-27 | Hitachi Chemical Co Ltd | 癌の切除手術後の予後を判定するためのデータ分析方法 |
-
2016
- 2016-02-24 MX MX2017010836A patent/MX386750B/es unknown
- 2016-02-24 HK HK18105993.6A patent/HK1246828A1/zh unknown
- 2016-02-24 DK DK16710678.0T patent/DK3262190T3/da active
- 2016-02-24 UA UAA201708275A patent/UA124612C2/uk unknown
- 2016-02-24 AU AU2016223532A patent/AU2016223532B2/en not_active Ceased
- 2016-02-24 JP JP2017562131A patent/JP6807873B2/ja not_active Expired - Fee Related
- 2016-02-24 CN CN201680010907.3A patent/CN107406880A/zh active Pending
- 2016-02-24 EP EP16710678.0A patent/EP3262190B1/en active Active
- 2016-02-24 WO PCT/EP2016/053813 patent/WO2016135168A1/en not_active Ceased
- 2016-02-24 KR KR1020177025428A patent/KR20170120124A/ko not_active Ceased
- 2016-02-24 CA CA2975952A patent/CA2975952C/en active Active
- 2016-02-24 EA EA201791578A patent/EA037995B1/ru unknown
- 2016-02-24 ES ES16710678T patent/ES2893297T3/es active Active
- 2016-02-24 US US15/552,421 patent/US10941451B2/en not_active Expired - Fee Related
- 2016-02-24 PL PL16710678T patent/PL3262190T3/pl unknown
-
2017
- 2017-07-31 IL IL253756A patent/IL253756B/en active IP Right Grant
-
2020
- 2020-12-07 JP JP2020202783A patent/JP2021052777A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018509934A5 (cg-RX-API-DMAC7.html) | ||
| Andrade et al. | Drug-induced liver injury | |
| Hiltermann et al. | Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor | |
| Soni et al. | Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity | |
| JP2016500110A5 (cg-RX-API-DMAC7.html) | ||
| JP2014002170A5 (cg-RX-API-DMAC7.html) | ||
| JP2015522165A5 (cg-RX-API-DMAC7.html) | ||
| JP2017504011A5 (cg-RX-API-DMAC7.html) | ||
| EP2081132A3 (en) | Novelty detection | |
| NZ701807A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| RU2014112350A (ru) | Способ детекции нуклеосом, содержащих нуклеотиды | |
| RU2014112348A (ru) | Способ детекции нуклеосом, содержащих гистоновые варианты | |
| EP2759259A3 (en) | Apparatus and method for measuring stress based on a behavior of a user | |
| JP2020514689A5 (cg-RX-API-DMAC7.html) | ||
| CN108277278A (zh) | 一种用于正常核型急性髓系白血病预后分层的方法及装置 | |
| Zhang et al. | Prognostic significance of combining VEGFA, FLT1 and KDR mRNA expression in lung cancer | |
| BR112012014954A2 (pt) | método para diagnosticar tumor maligno | |
| JP2018529931A5 (cg-RX-API-DMAC7.html) | ||
| Liang et al. | Effect of sensor number and distribution on accuracy rate of wood defect detection with stress wave tomography | |
| JP2019510974A5 (cg-RX-API-DMAC7.html) | ||
| Blute Jr et al. | Metastatic tumor burden does not predict overall survival following cytoreductive nephrectomy for renal cell carcinoma: a novel 3-dimensional volumetric analysis | |
| JP2020079729A5 (cg-RX-API-DMAC7.html) | ||
| JP2015095602A5 (cg-RX-API-DMAC7.html) | ||
| JP2016080672A (ja) | 悪性リンパ腫の検出法 | |
| Billingham et al. | Trial designs to assess biomarkers in clinical practice |